Literature DB >> 6505692

Monoclonal idiotope vaccine against Streptococcus pneumoniae infection.

M K McNamara, R E Ward, H Kohler.   

Abstract

A monoclonal anti-idiotope antibody coupled to a carrier protein was used to immunize BALB/c mice against a lethal Streptococcus pneumoniae infection. Vaccinated mice developed a high titer of antibody to phosphorylcholine, which is known to protect against infection with Streptococcus pneumoniae. Measurement of the median lethal dose of the bacteria indicated that anti-idiotope immunization significantly increased the resistance of BALB/c mice to the bacterial challenge. Antibody to an idiotope can thus be used as an antigen substitute for the induction of protective immunity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6505692     DOI: 10.1126/science.6505692

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  41 in total

1.  Immune responses during human Schistosomiasis mansoni. Evidence for antiidiotypic T lymphocyte responsiveness.

Authors:  M S Lima; G Gazzinelli; E Nascimento; J C Parra; M A Montesano; D G Colley
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

2.  Current approaches to vaccine preparation.

Authors:  J J Liu; A Cepica
Journal:  Can Vet J       Date:  1990-03       Impact factor: 1.008

3.  Monoclonal 'internal image' anti-idiotypic antibodies of hepatitis B surface antigen.

Authors:  Y M Thanavala; A Bond; R Tedder; F C Hay; I M Roitt
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

4.  Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniae.

Authors:  S L Harris; M K Park; M H Nahm; B Diamond
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 5.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

Review 6.  Possible role of anti-idiotypic antibodies in the induction of tumor immunity.

Authors:  R C Kennedy; E M Zhou; R E Lanford; T C Chanh; C A Bona
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

7.  Idiotype vaccine for tumor by anti-idiotypic antibody prepared against anti-(bacillus Calmette Guèrin)BCG monoclonal antibody.

Authors:  J Sasaki; T Tamagake; S Narita; C R Ahsan
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

8.  Foot-and-mouth disease virus-neutralizing antibodies induced in mice by anti-idiotypic antibodies.

Authors:  A E Garmendia; D O Morgan; B Baxt
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

9.  Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72.

Authors:  K Irvine; J Schlom
Journal:  Cancer Immunol Immunother       Date:  1993-05       Impact factor: 6.968

10.  Liposomes containing anti-idiotypic antibodies: an oral vaccine to induce protective secretory immune responses specific for pathogens of mucosal surfaces.

Authors:  S Jackson; J Mestecky; N K Childers; S M Michalek
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.